Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis
Veronica Veschi, Francesco Verona, Melania Lo Iacono, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Advancements in current one-size-fits-all therapies compared to future treatment innovations for better improved chemotherapeutic outcomes: a step-toward personalized medicine
Nadia Μ. Hamdy, Emad B. Basalious, Mona G. El-Sisi, et al.
Current Medical Research and Opinion (2024) Vol. 40, Iss. 11, pp. 1943-1961
Closed Access | Times Cited: 11
Cancer stem cells and tumor-associated macrophages as mates in tumor progression: mechanisms of crosstalk and advanced bioinformatic tools to dissect their phenotypes and interaction
Francesco Verona, Sebastiano Di Bella, Roberto Schirano, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells
Veronica Veschi, Alice Turdo, Chiara Modica, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 17
Targeting Phosphatases and Kinases: How to Checkmate Cancer
Alice Turdo, Caterina D’Accardo, Antonino Glaviano, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 38
Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment
Miriam Gaggianesi, Simone Di Franco, Vincenzo Davide Pantina, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 35
SOX4 is a pivotal regulator of tumorigenesis in differentiated thyroid cancer
Chi‐Yu Kuo, Yi‐Chiung Hsu, Chien‐Liang Liu, et al.
Molecular and Cellular Endocrinology (2023) Vol. 578, pp. 112062-112062
Closed Access | Times Cited: 14
Epigenetic marvels: exploring the landscape of colorectal cancer treatment through cutting-edge epigenetic-based drug strategies
Azar Tahghighi, Effat Seyedhashemi, Javad Mohammadi, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access
ADH1B regulates tumor stemness by activating the cAMP/PKA/CREB1 signaling axis to inhibit recurrence and metastasis of lung adenocarcinoma
Hai-Rong Shi, Youtao Xu, Guoxin Song, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151681-151681
Closed Access
Roles and new Insights of Macrophages in the Tumor Microenvironment of Thyroid Cancer
Qi Liu, Wei Sun, Hao Zhang
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
Targeting epigenetic alterations in cancer stem cells
Francesco Verona, Vincenzo Davide Pantina, Chiara Modica, et al.
Frontiers in Molecular Medicine (2022) Vol. 2
Open Access | Times Cited: 14
Targeting Hepatic Cancer Stem Cells (CSCs) and Related Drug Resistance by Small Interfering RNA (siRNA)
Saade Abdalkareem Jasim, Omar Dheyauldeen Salahdin, H. Malathi, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 4, pp. 3031-3051
Closed Access | Times Cited: 2
The role of epigenetic methylations in thyroid Cancer
Xiaojie Yu, Hao Zhang, Haojie Zhang, et al.
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Thyroid Cancer Stem-Like Cells: From Microenvironmental Niches to Therapeutic Strategies
Elisa Grassi, Viola Ghiandai, Luca Persani
Journal of Clinical Medicine (2021) Vol. 10, Iss. 7, pp. 1455-1455
Open Access | Times Cited: 15
Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy
Melania Lo Iacono, Miriam Gaggianesi, Paola Bianca, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 23, pp. 6996-6996
Open Access | Times Cited: 9
Novel insights into cancer stem cells targeting: CAR-T therapy and epigenetic drugs as new pillars in cancer treatment
Veronica Veschi, Alice Turdo, Giorgio Stassi
Frontiers in Molecular Medicine (2023) Vol. 3
Open Access | Times Cited: 4
TMEM252 inhibits epithelial–mesenchymal transition and progression in papillary thyroid carcinoma by regulating Notch1 expression
Shuyong Zhang, Rong Xie, Liuhuan Wang, et al.
Head & Neck (2024) Vol. 47, Iss. 1, pp. 324-338
Closed Access | Times Cited: 1
Cancer cell targeting by CAR-T cells: A matter of stemness
Caterina D’Accardo, Gaetana Porcelli, Laura Rosa Mangiapane, et al.
Frontiers in Molecular Medicine (2022) Vol. 2
Open Access | Times Cited: 5
Selective Antitumor Activity of Datelliptium toward Medullary Thyroid Carcinoma by Downregulating RET Transcriptional Activity
Tariq Alqahtani, Abdullah Alswied, Daekyu Sun
Cancers (2021) Vol. 13, Iss. 13, pp. 3288-3288
Open Access | Times Cited: 7
Utilizing CD44v6 and V600EBRAF-mutation for in vitro targeted combination therapy of thyroid carcinomas
Anja C. Mortensen, Juliana Imgenberg‐Kreuz, Diana Spiegelberg, et al.
Heliyon (2023) Vol. 9, Iss. 12, pp. e22594-e22594
Open Access | Times Cited: 2
Quercetin induces proteolysis of mesenchymal marker vimentin through activation of caspase-3, and decreases cancer stem cell population in human papillary thyroid cancer cell line.
Devavrat Tripathi, Pramod Gupta, Sharmila Banerjee, et al.
Phytomedicine Plus (2021) Vol. 1, Iss. 4, pp. 100108-100108
Open Access | Times Cited: 5
Intramedullary Spinal Cord Metastases from Differentiated Thyroid Cancer, a Case Report
Fabio Volpe, Leandra Piscopo, Mariarosaria Manganelli, et al.
Life (2022) Vol. 12, Iss. 6, pp. 863-863
Open Access | Times Cited: 3
Pan-cancer analysis reveals a regulatory pattern of anoikis in human cancers
Xiaoyun Wang, Chao Yang, Xingjian Wang, et al.
Cellular and Molecular Biology (2024) Vol. 70, Iss. 2, pp. 51-61
Open Access
Research progress of immunotherapy against anaplastic thyroid cancer
Jiaqian Chen, Zuixuan Xiao, Hongyan Wu
Frontiers in Oncology (2024) Vol. 14
Open Access
Terrestrosin D inhibits invasion and induces apoptosis through inhibition of STAT3 in anaplastic thyroid carcinoma
Honglai Zhang, Dawei Sun, Peijie Lei, et al.
Molecular & Cellular Toxicology (2024)
Closed Access
Involvement of epigenetic modifications in cancer stem cells and chemoresistance
Prajakta Oak, Chitra Thakur
Elsevier eBooks (2024), pp. 199-213
Closed Access
Page 1 - Next Page

Scroll to top